These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22875722)

  • 1. Prediction of health preference values from CD4 counts in individuals with HIV.
    Isogai PK; Rueda S; Rachlis AR; Rourke SB; Mittmann N;
    Med Decis Making; 2013 May; 33(4):558-66. PubMed ID: 22875722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical signs and symptoms in the assessment of immunodeficiency in men with subtype C HIV infection in Harare, Zimbabwe.
    Machekano R; Bassett M; McFarland W; Katzenstein D
    HIV Clin Trials; 2002; 3(2):148-54. PubMed ID: 11976993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country.
    Edathodu J; Ali B; Alrajhi AA
    Int J Infect Dis; 2009 Mar; 13(2):243-6. PubMed ID: 18945632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
    Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of initial CD4+ T-cell counts at the time of diagnosis of HIV infection in Korea; 1988-2006.
    Kee MK; Lee JH; Kim GJ; Choi BS; Hong KJ; Lee JS; Kim SS
    Int J STD AIDS; 2010 Feb; 21(2):120-5. PubMed ID: 20089998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilities derived from visual analog scale scores in patients with HIV/AIDS.
    Mrus JM; Yi MS; Freedberg KA; Wu AW; Zackin R; Gorski H; Tsevat J
    Med Decis Making; 2003; 23(5):414-21. PubMed ID: 14570299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
    Mbanya D; Assah F; Ndembi N; Kaptue L
    Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nutritional status of the persons living with HIV/AIDS; its relationship with T CD4+ cells counts].
    Linares Guerra EM; Santana Porbén S; Carrillo Fornés O; León Sánchez MA; Sanabria Negrín JG; Acosta Núñez N; Pla Cruz A; Coniell Linares E
    Nutr Hosp; 2013 Nov; 28(6):2197-207. PubMed ID: 24506402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical benefits of ritonavir-boosted TMC114 from treatment effects on CD4 counts and HIV RNA.
    Hill A; Montaner J; Smith C
    HIV Med; 2007 May; 8(4):234-40. PubMed ID: 17461851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis.
    Bogaards JA; Weverling GJ; Geskus RB; Miedema F; Lange JM; Bossuyt PM; Goudsmit J
    Antivir Ther; 2003 Feb; 8(1):43-50. PubMed ID: 12713063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.